Original Research
Published on 31 Mar 2025
Physiologically based pharmacokinetic model of sodium-glucose cotransporter 2 inhibitors predicted pharmacokinetics and pharmacodynamics to explore dosage regimen for patients with type 2 diabetes mellitus and renal insufficiency
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1520268
- 4,079 views
- 2 citations


